(PO24-21-22) Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

DL

Delia Pei Shan Lee, B.Sc.
– Ph.D. Candidate, National University of Singapore, Singapore, Singapore

Co-Author(s)

AG

Alicia Xinli Gan, B.Sc.
– Research Assistant, National University of Singapore, Singapore, Singapore
XX

Xuejuan Xia, PhD
– National University of Singapore
KT

Kate Qi Xuan Toh
– National University of Singapore
GC

Gregory Chan
– National University of Singapore
SJ

Sangyong Jung
– National University of Singapore
JK

Jung Eun Kim, Ph.D., R.D.
– Assistant Professor, National University of Singapore, Singapore, Singapore

Disclosure(s):

Delia Pei Shan Lee, B.Sc.: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the gut microbiota to generate gut metabolites involved in gut health maintenance. This study evaluates the impact of okara and biovalorized okara- containing biscuits consumption on gut health in middle-aged and older Singaporeans.

Methods: Healthy participants (n = 15) of the crossover trial were randomly allocated to 3-week interventions of 100 g of control (C), 20% flour substituted autoclaved okara- (AOK), and 20% four substituted R. oligosporus biovalorized okara- (RO) containing biscuits, with 3-week washout periods. Pre- and post- intervention serum short-chain fatty acids (SCFA), fecal SCFA, fecal bile acids, serum zonulin, gastrointestinal symptoms, and dietary intakes were assessed. Pre- and post- intervention fecal 16S ribosomal RNA V3-V4 sequencing was also investigated for gut microbiome analysis. Results are presented as change value mean (95% confidence interval).

Results: Amongst fecal SCFA, only valeric acid (µmol/g) observed a significant difference, higher with RO compared to AOK (0.16 (0.01, 0.30) vs -0.20 (-0.34, -0.05), P = 0.005). RO and AOK had significantly higher total serum SCFA (P = 0.002 & 0.018 respectively) and serum acetic acid (P = 0.007 & 0.030 respectively) compared to C. RO had significant improvements with higher serum propionic acid (µmol/L) (RO: 3.04 (0.80, 5.27) vs C: -2.65 (-4.97, -0.33), P = 0.004) and lower fecal lithocholic acid (mg/g) (a secondary bile acid) (RO: -0.11 (-0.20, -0.02) vs C: 0.10 (0.01, 0.19), P = 0.009) contrasted to C. Although serum zonulin showed no significant difference, AOK induced a reduction in Clostridiales while RO increased Bifidobacterium. Okara consumption increased dietary fiber intake, with greater soluble fiber intake from RO compared to AOK and C (P = 0.018 & 0.019 respectively), aligning with the greater flatulence felt by participants on RO.

Conclusions: Okara consumption improved serum SCFA rather than fecal SCFA, regardless of fermentation. Biovalorized okara consumption further improved SCFA and bile acid profiles by modulating gut microbiome.

Funding Sources: Singapore Ministry of Education